Taysha
is a Texas-based biotechnology company that researches and develops gene therapies for the treatment of monogenic central nervous system disorders... Read moreTaysha
is a Texas-based biotechnology company that researches and develops gene therapies for the treatment of monogenic central nervous system disorders... Read more
2019
PublicIndependent CompanyNASDAQTSHA
News
Feb 27, 2025
Owler
Taysha Gene Therapies, Inc.: Taysha's employee count changed from 52 in Dec 2023 to 73 in Dec 2024
Feb 26, 2025
Marketscreener
Taysha: Taysha Gene Therapies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2024
Feb 19, 2025
GlobeNewswire
Press Release: Taysha : Taysha Gene Therapies to Release Full-Year 2024 Financial Results and Host Conference Call and Webcast on February 26
Nov 14, 2024
Seeking Alpha
Taysha: Taysha Gene Therapies, Inc. (TSHA) Q3 2024 Earnings Call Transcript
Nov 13, 2024
Zacks
Taysha: Taysha Gene Therapies, Inc. (TSHA) Reports Q3 Loss, Lags Revenue Estimates
Nov 13, 2024
Marketscreener
Taysha: Taysha Gene Therapies, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024
Aug 12, 2024
Owler
Taysha Gene Therapies, Inc.: Taysha's revenue changed from $14.16M in Mar 2024 to $12.87M in Jun 2024
Jul 05, 2024
BioSpace
Taysha: Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - July 05, 2024
Jul 03, 2024
PharmaLive
Taysha: Taysha shares positive Rett results in bid to move past roadblocks
Jun 26, 2024
Citybizlist
Taysha: Taysha Gene Therapies Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
Taysha Competitors
1
2
3
4
5
6